Sernova Corp. is a Canada-based clinical-stage company, which is engaged in developing products for the treatment of chronic debilitating diseases using the Cell Pouch system. The Company’s technologies include Cell Pouch System and Sertolin Technology. Cell Pouch System is implantable and scalable medical device. Sertolin technology provides an immune-protected local environment for transplanted therapeutic cells such as insulin producing islets. The Company’s Cell Pouch system combined with its Sertolin immune protection technology offers therapeutic cells local protection from immune system attack creating an effective, safe, long-term and convenient therapeutic option for patients with chronic disease.